EHAB
Enhabit, Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$13.80
+0.07%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 1.1B | 1.0B | 1.0B | 1.1B |
| Cost of Revenue | 554.5M | 562.7M | 530.8M | 535.6M | 525.6M |
| Gross Profit | 510.4M | 497.3M | 504.0M | 510.7M | 545.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 422.7M | 433.5M | 425.9M | 441.6M | 414.9M |
| General & Admin Expense | 422.7M | 433.5M | 425.9M | 441.6M | 414.9M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 10.5M | — | 193.2M | 116.7M | 142.0M |
| Total Operating Expenses | 433.2M | 433.5M | 619.1M | 558.3M | 556.9M |
| Cost and Expenses | 987.7M | 996.2M | 1.1B | 1.1B | 1.1B |
| Operating Income (EBIT) | 77.2M | 63.8M | (115.1M) | (47.6M) | (11.4M) |
| Non-Operating | |||||
| Interest Income | 3.8M | 200.0K | — | — | — |
| Interest Expense | 34.6M | 34.0M | 42.9M | 43.0M | 15.0M |
| Net Interest Income | (30.8M) | (33.8M) | (42.9M) | (43.0M) | (15.0M) |
| Other Non-Op Income/Expense | (72.2M) | (62.4M) | (42.9M) | (42.8M) | (14.1M) |
| Non-Operating Income (excl Interest) | 41.3M | — | — | (200.0K) | (900.0K) |
| EBT (Pre-Tax Income) | 5.0M | 1.4M | (158.0M) | (90.4M) | (25.5M) |
| Income Tax Expense | 6.1M | 4.0M | (4.0M) | (11.4M) | 12.8M |
| Bottom Line | |||||
| Net Income | (3.2M) | (4.6M) | (156.2M) | (80.5M) | (40.4M) |
| Earnings from Cont. Ops | (1.1M) | (2.6M) | (154.0M) | (79.0M) | (38.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (3.2M) | (4.6M) | (156.2M) | (80.5M) | (40.4M) |
| Per Share | |||||
| Basic EPS | ($0.06) | ($0.09) | ($3.11) | ($1.61) | $1.25 |
| Diluted EPS | ($0.08) | ($0.09) | ($3.11) | ($1.61) | $1.25 |
| Revenue Per Share | $20.80 | $20.87 | $20.61 | $20.90 | $21.38 |
| Shares | |||||
| Basic Shares Outstanding | 51.2M | 50.8M | 50.2M | 50.1M | 50.1M |
| Diluted Shares Outstanding | 52.9M | 50.8M | 50.2M | 49.9M | 50.1M |
| Profitability Metrics | |||||
| EBITDA | 56.7M | 86.3M | (83.6M) | (16.5M) | 22.5M |
| D&A | 20.8M | 22.5M | 31.5M | 30.9M | 33.0M |
| EBIT | 35.9M | 63.8M | (115.1M) | (47.4M) | (10.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026